Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F0ZU0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $175,915
Award facts
- Contract value 100% obligated
- $175,915.05 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $175,915 to AmerisourceBergen Drug Corp for the supply of Dupixent (dupilumab) 300 mg/2 mL pen auto-injectors on January 12, 2026, with a completion date of January 13, 2026. This non-competed delivery order was fulfilled from the contractor's place of performance in Conshohocken, Pennsylvania. The award represents a task order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor providing a comprehensive range of medications and medical supplies to federal government healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The Dupixent delivery fulfills critical medical supply needs for military treatment facilities and veteran healthcare programs. As a firm fixed-price award with no set-aside designation, this contract demonstrates the contractor's capability to compete on a full and open basis and efficiently deliver specialized pharmaceutical commodities required by federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26F0ZU0?
SPE2DR26F0ZU0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26F0ZU0 worth?
The government has obligated $175,915 on SPE2DR26F0ZU0.
Is contract SPE2DR26F0ZU0 an order under another contract?
Yes. SPE2DR26F0ZU0 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F0ZU0 competed?
The extent of competition for SPE2DR26F0ZU0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award